IL1B and colorectal carcinoma: The -31 T/C polymorphism of this gene is associated with colorectal cancer risk, as IL-1B-511 heterozygotes and T carriers has reduced risk of colorectal carcinoma development [34] and it is associated with the recurrence of CRC [35].